Antioxidants and Redox Signaling · 2016 · 91 citations · 44 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer MetabolismMetabolic ReprogrammingMetabolic Reprogramming In CancerOncogenic Signaling PathwaysReactive Oxygen SpeciesThyroid CancerCancer Cell Nadph MetabolismMitogen-activated Protein Kinase KinaseMitogen-activated Protein Kinase SignalingNadph Oxidase ActivityNadph Oxidase BiologyRadioiodine RefractorinessReactive Oxygen Species GenerationThyroid Cancer Genetics
Aims: The BRAFV600E oncogene, reported in 40%–60% of papillary thyroid cancer (PTC), has an important role in the pathogenesis of PTC. It is associated with the loss of thyroid iodide-metabolizing genes, such as sodium/iodide symporter (NIS), and therefore with radioiodine refractoriness. Inhibition of mitogen-activated protein kinase (MAPK) pathway, constitutively activated by BRAFV600E, is not always efficient in resistant tumors suggesting that other compensatory mechanisms contribute to a BRAFV600E adaptive resistance. Recent studies pointed to a key role of transforming growth factor β (TGF-β) in BRAFV600E-induced effects. The reactive oxygen species (ROS)-generating NADPH oxidase NOX4, which is increased in PTC, has been identified as a new key effector of TGF-β in cancer, suggestive of a potential role in BRAFV600E-induced thyroid tumors. Results: Here, using two human BRAFV600E-mutated thyroid cell lines and a rat thyroid cell line expressing BRAFV600E in a conditional manner, we show that NOX4 upregulation is controlled at the transcriptional level by the oncogene via the TGF-β/Smad3 signaling pathway. Importantly, treatment of cells with NOX4-targeted siRNA downregulates BRAFV600E-induced NIS repression. Innovation and Conclusion: Our results establish a link between BRAFV600E and NOX4, which is confirmed by a comparative analysis of NOX4 expression in human (TCGA) and mouse thyroid cancers. Remarkably, analysis of human and murine BRAFV600E-mutated thyroid tumors highlights that the level of NOX4 expression is inversely correlated to thyroid differentiation suggesting that other genes involved in thyroid differentiation in addition to NIS might be silenced by a mechanism controlled by NOX4-derived ROS. This study opens a new opportunity to optimize thyroid cancer therapy. Antioxid. Redox Signal. 26, 864–877.
44
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy et al. · Cell · 2014 · 3.1K citations · Full text
Cloning and characterization of the thyroid iodide transporter
Ge Dai, Orlie Levy, Nancy Carrasco · Nature · 1996 · 1.1K citations
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson et al. · JAMA · 2013 · 926 citations
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho, Ravinder K. Grewal, Rébecca Leboeuf et al. · New England Journal of Medicine · 2013 · 829 citations · Full text